Clinical implication of 18F-fluorodeoxyglucose PET/CT in monitoring disease activity in spondyloarthritis.

Rheumatology (Oxford, England)

Volumn 49, Issue 4, 2010, Pages 829-

  Taniguchi, Yoshinori ^a   Kumon, Yoshitaka ^b   Arii, Kaoru ^b   Tsugita, Makoto ^b   Fukumoto, Mitsutaka ^b   Ohnishi, Takenao ^b   Kobayashi, Shigeto ^b   Terada, Yoshio ^b  

^a KOCHI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CASE REPORT; HUMAN; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SPINE; SPONDYLARTHRITIS;

AGED; ANTI-INFLAMMATORY AGENTS; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; SPINE; SPONDYLARTHRITIS;

EID: 77953476299     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep466     Document Type: Article

References (0)